Availability of data and material
All data are available and can be provided if requested.
References
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134. https://doi.org/10.1002/art.1780330811
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al (2006) ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47(6):1239–1312. https://doi.org/10.1016/j.jacc.2005.10.009
Messerli FH, Bangalore S, Makani H, Rimoldi SF, Allemann Y, White CJ et al (2011) Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J 32(18):2231–2235. https://doi.org/10.1093/eurheartj/ehr056
Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA et al (1988) Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 2(8610):551–552. https://doi.org/10.1016/s0140-6736(88)92668-2
Shantsila A, Shantsila E, Beevers DG, Lip GYH (2017) Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. J Hypertens 35(11):2310–2314. https://doi.org/10.1097/hjh.0000000000001446
Hu YF, Tan Y, Yu XJ, Wang H, Wang SX, Yu F et al (2020) Podocyte involvement in renal thrombotic microangiopathy: a clinicopathological study. Am J Nephrol 51(9):752–760. https://doi.org/10.1159/000510141
Mason JC (2010) Takayasu arteritis—advances in diagnosis and management. Nat Rev Rheumatol 6(7):406–415. https://doi.org/10.1038/nrrheum.2010.82
Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929. https://doi.org/10.7326/0003-4819-120-11-199406010-00004
Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A (2016) Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 29(4):495–505. https://doi.org/10.1007/s40620-016-0303-8
Kos I, Stilgenbauer S, Bewarder M (2020) Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature. Clin Res Cardiol 109(11):1438–1441. https://doi.org/10.1007/s00392-020-01655-4
González-Gay MA, Castañeda S (2018) Rituximab in Takayasu arteritis: an unmet hope. Rheumatology (Oxford) 57(7):1133–1134. https://doi.org/10.1093/rheumatology/kex326
Keser G, Aksu K, Direskeneli H (2018) Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited. Rheumatology (Oxford) 57(5):784–790. https://doi.org/10.1093/rheumatology/kex333
Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E et al (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79(1):19–30. https://doi.org/10.1136/annrheumdis-2019-215672
Kötter I, Henes JC, Wagner AD, Loock J, Gross WL (2012) Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Clin Exp Rheumatol 30(1 Suppl 70):S114–S129
Galarza C, Valencia D, Tobón GJ, Zurita L, Mantilla RD, Pineda-Tamayo R et al (2008) Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases? Clin Rev Allergy Immunol 34(1):124–128. https://doi.org/10.1007/s12016-007-8028-z
Caltran E, Di Colo G, Ghigliotti G, Capecchi R, Catarsi E, Puxeddu I et al (2014) Two Takayasu arteritis patients successfully treated with rituximab. Clin Rheumatol 33(8):1183–1184. https://doi.org/10.1007/s10067-014-2506-5
Hoyer BF, Mumtaz IM, Loddenkemper K, Bruns A, Sengler C, Hermann KG et al (2012) Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis 71(1):75–79. https://doi.org/10.1136/ard.2011.153007
Pazzola G, Muratore F, Pipitone N, Crescentini F, Cacoub P, Boiardi L et al (2018) Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature. Rheumatology (Oxford) 57(7):1151–1155. https://doi.org/10.1093/rheumatology/kex249
Samson M, Espígol-Frigolé G, Terrades-García N, Prieto-González S, Corbera-Bellalta M, Alba-Rovira R et al (2018) Biological treatments in giant cell arteritis & Takayasu arteritis. Eur J Intern Med 50:9–12. https://doi.org/10.1016/j.ejim.2017.11.003
Acknowledgements
The authors would like to thank the patient and her family for granting us their permission to publish this case report.
Funding
The present article received no external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Ethics approval
All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent for publication
The provided information is anonymous and does not expose the identity of the patient. The patient gave Informed Consent to the publication of the report.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fang, S., Zhou, Xj., Cui, Z. et al. A 16-year-old girl with sudden heart failure and nephrotic syndrome associated with Takayasu’s arteritis. Clin Res Cardiol 111, 221–226 (2022). https://doi.org/10.1007/s00392-021-01893-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-021-01893-0